References: 1. Dikman AE, Schonfeld E, Srisarajivakul NC, et al. Human immunodeficiency virus-associated diarrhea: still an issue in the era of antiretroviral therapy. Dig Dis Sci. 2015;60:2236–2245. doi:10.1007/s10620-015-3615-y 2. Castro JG, Chin-Beckford N. Crofelemer for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. Expert Rev Clin Pharmacol. 2015;8(6):683-690. doi:10.1586/17512433.2015.1082424 3. Sankaran S, George MD, Reay E, et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol. 2008;82(1):538-545. doi:10.1128/JVI.01449-07 4. Siddiqui U, Bini EJ, Chandarana K, et al. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy. J Clin Gastroenterol. 2007;41(5):484-490. doi:10.1097/01.mcg.0000225694.46874.fc 5. Clay PG, Suzuki S, Chaturvedi P, Macfarlane K. PLWH are more than viral loads and CD4 counts: Improving Quality of Life & Work Productivity through Diarrhea Reduction. In: 13th International Conference on HIV Treatment and Prevention Adherence. Miami, FL; 2018.